Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer

Chest

Volumn 151, Issue 3, 2017, Pages 525-526

  Ravenel, James G ^a   Tanner, Nichole T ^b,c   Silvestri, Gerard A ^c  

^a Department of Radiology and Radiologic Sciences ^*  (United States)

^b Thoracic Oncology Research Group   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; EDITORIAL; FALSE POSITIVE RESULT; HUMAN; LUNG CANCER; LUNG NODULE; PLEURA EFFUSION; PRACTICE GUIDELINE; PREDICTIVE VALUE; EARLY CANCER DIAGNOSIS; FOREST; INFORMATION PROCESSING; LUNG TUMOR; TREE; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

DATA SYSTEMS; EARLY DETECTION OF CANCER; FORESTS; HUMANS; LUNG NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREES; UNITED STATES;

EID: 85014521764     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.10.053     Document Type: Editorial

References (14)

1. 1 Moyer, V.A., U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:5 (2014), 330–338.
2. 2 Aberle, D.R., Adams, A.M., Berg, C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:5 (2011), 395–409.
3. 3 Center For Medicare and Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT). 2015. https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed December 1, 2016.
4. 4 Mazzone, P., Powell, C.A., Arenberg, D., et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society policy statement. Chest 147:2 (2015), 295–303.
5. 5 Wiener, R.S., Gould, M.K., Arenberg, D.A., et al. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med 192:7 (2015), 881–891.
6. 6 Mehta, H.J., Mohammed, T.L., Jantz, M.A., The American College of Radiology lung imaging reporting and data system: potential drawbacks and need for revision. Chest 151:3 (2017), 539–543.
7. 7 Pinsky, P.F., Gierada, D.S., Black, W., et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 162:7 (2015), 485–491.
8. 8 Aberle, D.R., DeMello, S., Berg, C.D., et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369:10 (2013), 920–931.
9. 9 Kazerooni, E.A., Austin, J.H., Black, W.C., et al. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (resolution 4). J Thorac Imaging 29 (2014), 310–316.
10. 10 Moseson, E.M., Wiener, R.S., Golden, S.E., et al. Patient and clinician characteristics associated with adherence. A cohort study of veterans with incidental pulmonary nodules. Ann Am Thorac Soc 13:5 (2016), 651–659.
11. 11 Blagev, D.P., Lloyd, J.F., Conner, K., et al. Follow-up of incidental pulmonary nodules and the radiology report. J Am Coll Radiol 13:2 suppl (2016), R18–R24.
12. 12 Silvestri, G.A., Screening for lung cancer: it works, but does it really work?. Ann Intern Med 155:8 (2011), 537–539.
13. 13 Tanner, N.T., Aggarwal, J., Gould, M.K., et al. Management of pulmonary nodules by community pulmonologists: a multicenter observational study. Chest 148:6 (2015), 1405–1414.
14. 14 Gould, M.K., Donington, J., Lynch, W.R., et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5 suppl), 2013 e93S-120S.